Long-Term Assets: The sum of all assets classified as non-current.
Pasithea Therapeutics Corp. (KTTA) had Long-Term Assets of $3.47M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-5.27M |
|
-- |
|
-- |
|
$5.71M |
|
$-5.71M |
|
$0.44M |
|
$-5.27M |
|
$-5.27M |
|
$-5.27M |
|
$-5.27M |
|
$-5.27M |
|
$-5.27M |
|
$-5.71M |
|
$-5.56M |
|
32.10M |
|
32.10M |
|
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$48.24M |
|
-- |
|
|
Long-Term Assets |
$3.47M |
$51.71M |
|
$1.84M |
|
-- |
|
$0.03M |
|
$1.87M |
|
$49.84M |
|
$46.37M |
|
$49.84M |
|
33.41M |
|
| Cash Flow Statement Financials | |
$-9.49M |
|
-- |
|
$0.01M |
|
$55.26M |
|
$45.77M |
|
$-9.49M |
|
$0.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
26.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.49M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.58% |
|
-11.37% |
|
-10.20% |
|
-10.58% |
|
$1.49 |
|
$-0.30 |
|
$-0.30 |
|